August 25, 2016 4:13 AM ET

Biotechnology

Company Overview of Indel Therapeutics Inc

Company Overview

Indel Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibiotics to address the global health crisis caused by antibiotic resistance. It also grows a pipeline of novel antibiotic drug discovery programs focused on curing difficult to treat and hospital acquired infections. Indel Therapeutics was founded in 2008 and is based in Vancouver, Canada.

4068 West 11th Avenue

Suite 100

Vancouver, BC V6R 2L3

Canada

Founded in 2008

Phone:

604-551-8464

Fax:

604-909-1811

Key Executives for Indel Therapeutics Inc

Chief Executive Officer and Director
Consulting Vice President of Research
Director of Preclinical Screening
Chairman of the Scientific Advisory Board, Chief Scientific Officer and Director
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
2007262 Ontario, Inc. Americas
2056273 Ontario, Inc. Americas
AB BioPharma Inc. Americas
AbCelex Technologies Inc. Americas
AbCellera Biologics Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Indel Therapeutics Inc, please visit www.indeltherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.